I missed that particular cruise...and,... All the
Post# of 148299
Speaking of navigating... the evolving landscape of Metastic Triple-Negative Breast Cancer pipeline therapeutics
Delveinsight... getnews.info/132264 June2, 2023...
Leading the charge... G1 Therapeutics....Cytodyn...Merck...Gilead Sciences...AstraZeneca...Hoffman LaRoche Celgene and others...At least we didn't end up in the "others" column.